Pfizer, Gilead and GSK to seize majority of the growing $150B infectious diseases market by 2029: report
Something that turned up earlier today
This turned up earlier today, and I posted it against a comment from ‘bawls’, in relation to potential customers being killed off by wall-to-wall mRNA jabbing:
Keep reading with a 7-day free trial
Subscribe to INSIDE PHARMA to keep reading this post and get 7 days of free access to the full post archives.